Your Trusted Source for TauroLock™ Catheter Lock Solutions
Exclusive Australia & New Zealand Partner and Distributor of
Providing Comprehensive Catheter Care with Proven TauroLock™ Solutions
As the exclusive distributor of TauroLock™ products in Australia, New Zealand, and the South Pacific, Prima MediPharm is proud to offer healthcare professionals a clinically proven solution to their catheter lock requirements. TauroLock™ products provide essential protection against infections, thrombosis, and biofilm formation, providing critical support for clinicians treating at-risk patients in environments such as oncology, dialysis, parenteral nutrition, and ICU.
Triple Efficacy
Clinically Proven Protection Against Occlusion, Infection, and Biofilm
Superior Infection Control
Prevention of Blockages and Thrombosis
Long-Term Biofilm Prevention
Cost-Effective and Safe
In comparison to other lock solutions, TauroLock™ products are safe for use from birth onwards, including for neonatal children. TauroLock™ solutions reduce catheter-associated costs by minimising the need for antibiotics, catheter replacements, and hospital readmissions.
TauroLock™ solutions’ clinical efficacy has been demonstrated across multiple studies, making it the safe choice for catheter management and has the added benefit of improving the patient’s inflammatory profile, thus improving patient outcomes.
Long-Term Biofilm Prevention
TauroLock™ solutions actively eradicate and prevent biofilm formation, a major cause of catheter malfunction and infection. Our Triple Efficacy solution not only removes existing biofilm but also prevents it from recurring, extending catheter life and performance.
Superior Infection Control
TauroLock™ solutions provide proven protection against catheter-related bloodstream infections (CRBSIs) by using taurolidine, an antimicrobial agent effective within 2 hours against over 500 pathogens, including antibiotic-resistant bacteria and fungi (including MRSA and VRE). TauroLock™ solutions’ powerful antimicrobial properties help ensure patient safety and reduce infection rates.
Prevention of Blockages and Thrombosis
Cost-Effective and Safe
In comparison to other lock solutions, TauroLock™ products are safe for use from birth onwards, including for neonatal children. TauroLock™ solutions reduce catheter-associated costs by minimising the need for antibiotics, catheter replacements, and hospital readmissions.
TauroLock™ solutions’ clinical efficacy has been demonstrated across multiple studies, making it the safe choice for catheter management and has the added benefit of improving the patient’s inflammatory profile, thus improving patient outcomes.
Learn More About TauroLock™
For more information, visit our supplier webpages where you’ll find downloadable informative materials, news, products, and more.
